Clinical Trials on Allergic Rhinitis/Rhinoconjunctivitis +- Intermittent Asthma

Total 1363 results

Novartis Pharmaceuticals

Completed

A Cross Over Study to Compare the Effect of Combined Treatment With QAV680 and Cetirizine

Allergic Rhinitis

Canada
GlaxoSmithKline

Completed

Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)

Rhinitis, Allergic, Seasonal

United States
AstraZeneca

Completed

Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408)

Rhinitis, Allergic, Perennial

United States
AstraZeneca

Completed

Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490)

Rhinitis, Allergic, Perennial

United States
GlaxoSmithKline

Completed

Allergen Challenge Chamber Study With Single Dose Oral GSK835726 Compared With Placebo

Rhinitis, Allergic, Seasonal

Germany
GlaxoSmithKline

Completed

Long Term Safety Of GW685698X Via Nasal Biopsy

Rhinitis, Allergic, Perennial

Netherlands, Belgium
GlaxoSmithKline

Completed

Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of Action

Rhinitis, Allergic, Seasonal

United States
Boehringer Ingelheim

Completed

Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® Tablet

Rhinitis, Allergic, Perennial
GlaxoSmithKline

Completed

A Phase-IV, Open-label Study to Evaluate Safety/Tolerability of Once-daily AVAMYS (TM) Aqueous Nasal Spray 110mcg Among Vietnamese Adult Patients With Established Perennial Allergic Rhinitis (AVY-REG00108VN)

Rhinitis, Allergic, Perennial

Vietnam
University of Chicago
Merck Sharp & Dohme LLC

Terminated

The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis

Rhinitis, Allergic, Perennial

United States
UCB Pharma

Completed

Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive Subjects

Rhinitis, Allergic, Seasonal
UCB Pharma

Completed

Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic Rhinitis

Rhinitis, Allergic, Seasonal
University of Chicago
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Withdrawn

Topical Allstate and Nasal Allergen Challenge

Allergic Rhinitis

United States
Dart NeuroScience, LLC
Orexo AB

Completed

Efficacy and Safety Study of BLX-028914 in Subjects With Allergic Rhinitis

Allergic Rhinitis

Sweden
Sanofi

Completed

Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR)

Rhinitis, Allergic, Perennial

United States
Sanofi

Completed

Fexofenadine Study On Filipino Children for The Relief of Perennial And Intermittent Allergic Rhinitis

Rhinitis, Allergic, Perennial

Philippines
UCB Pharma

Completed

Efficacy and Safety of Cetirizine Tablets Versus Ketotifen Dry Syrup in Children With Perennial Allergic Rhinitis

Rhinitis, Allergic, Perennial
Biolipox AB

Completed

Taste and Local Tolerance Study of NLA Nasal Spray in Patients With Allergic Rhinitis

Allergic Rhinitis

Sweden
University of Valencia
Hospital Universitario La Fe; Hospital General Universitario de Valencia; Hospital...

Completed

Intervention in Chronic Pediatric Patients and Their Families. (FACTORADAPT)

Asthma | Type 1 Diabetes | Allergic Rhinitis | Cystic Fibrosis | Pulmonary Disease | Atopic Dermatitis | Food Allergy | Allergic Asthma | Rhinoconjunctivitis | Primary Ciliary Dyskinesia | Short Stature

Spain
GlaxoSmithKline
PATH

Completed

A Study to Investigate the Safety and Pharmacodynamics of Repeat Intranasal Administration of the TLR7 Agonist GSK2245035 in Subjects With Respiratory Allergies

Asthma and Rhinitis

Canada
Organon and Co

Completed

A Study of Long-term Administration of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06333AM1)

Rhinitis, Allergic, Perennial
Zagazig University

Completed

Immunoblot, Chemiluminescence and ImmunoCap Allergen Specific IgE Evaluation of in Allergic Rhinitis Patients

Diagnoses Disease

Egypt
Imperial College London
ALK-Abelló A/S

Completed

Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and Asthma

Rhinitis, Allergic, Seasonal

United Kingdom
Chulalongkorn University

Completed

Acute Effects of Exercise at Different Temperatures in Allergic Rhinitis Patient

Allergic Rhinitis

Thailand
Organon and Co

Completed

Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04208)

Allergic Rhinitis
Organon and Co

Completed

Equivalency Study of Two Formulations of Mometasone Furoate Nasal Spray (Study P04419)

Rhinitis, Allergic, Perennial
Organon and Co

Completed

An Approved Drug to Study a New Indication for Allergic Rhinitis (0476-327)

Rhinitis, Allergic, Seasonal
Organon and Co

Completed

Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001)

Rhinitis, Allergic, Seasonal
MEDA Pharma GmbH & Co. KG
ClinResearch, GmbH; Prolytic GmbH; pharm-analyt GmbH

Completed

Single Dose Pharmacokinetics of Intranasal Fluticasone Delivered by a Fixed Combination With Azelastine (MP29 02) in Comparison to Two Different Fluticasone Nasal Sprays

Allergic Rhinitis

Germany
Helsinki University Central Hospital
University of Helsinki; Finnish Institute of Occupational Health

Completed

The Effects of Immunotherapy in the Nose (Birch11)

Rhinitis, Allergic, Seasonal
Eurofarma Laboratorios S.A.

Withdrawn

Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis (RINEX32)

Rhinitis, Allergic, Perennial

Brazil
University of Dundee

Completed

Alpha-Blockers in Allergic Rhinitis (MAN 01) (MAN01)

Allergic Rhinitis

United Kingdom
Pongsakorn Tantilipikorn
National Research Council of Thailand

Completed

Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais

Rhinitis, Allergic, Perennial

Thailand
Zhao Hong
Beijing Municipal Science & Technology Commission; China Academy of Chinese...

Completed

Effectivness and Safety of Acupuncture Combined With Moxibustion for Allergic Rhinitis

Rhinitis, Allergic, Perennial

China
GlaxoSmithKline

Completed

Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)

Rhinitis, Allergic, Perennial

Australia, Estonia, United States, Germany, Canada, New Zealand, Russian Federation, Lithuania, Latvia
GlaxoSmithKline

Completed

Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study.

Rhinitis, Allergic, Perennial

United States, Argentina, Canada, France, Peru, Italy, Chile
GlaxoSmithKline

Completed

Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male Subjects Whilst In An Environmental Chamber

Rhinitis, Allergic, Perennial

Germany
GlaxoSmithKline

Completed

Cetirizine Placebo Controlled Study For Perennial Allergic Rhinitis

Rhinitis, Allergic, Perennial

Japan
National Institute of Allergy and Infectious Diseases...
Imperial College London; Immune Tolerance Network (ITN)

Completed

Long-Term Effects of Sublingual Grass Therapy

Rhinitis, Allergic, Seasonal

United Kingdom
GlaxoSmithKline

Completed

A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) Rhinitis

Rhinitis, Allergic, Perennial

Thailand
GlaxoSmithKline

Completed

Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis

Rhinitis, Allergic, Perennial

Japan
Chong Kun Dang Pharmaceutical

Completed

Clinical Trial to Evaluate the Efficacy and Safety of CKD-342

Rhinitis, Allergic, Perennial

Korea, Republic of
GlaxoSmithKline

Completed

A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis

Rhinitis, Allergic, Perennial

Estonia, United States, Canada, Germany, Slovakia, Russian Federation, Hungary
GlaxoSmithKline

Completed

Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine

Rhinitis, Allergic, Seasonal

United States
AstraZeneca

Completed

Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602)

Rhinitis, Allergic, Seasonal

United States
GlaxoSmithKline

Completed

A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR)

Rhinitis, Allergic, Seasonal

Austria
GlaxoSmithKline

Completed

A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).

Rhinitis, Allergic, Perennial

United States, Canada
GlaxoSmithKline

Completed

Study In Adults And Adolescents With Seasonal Allergic Rhinitis.

Rhinitis, Allergic, Seasonal

Netherlands, Estonia, Russian Federation, Sweden, Latvia, Lithuania
Peking Union Medical College Hospital

Unknown

Effectiveness of Qufeng Shengshi Fang on Treatment of Allergic Rhinitis.

Rhinitis, Allergic, Perennial

China
Boehringer Ingelheim

Completed

Epinastine + Pseudoephedrine SR (Slow Release) Versus Epinastine Alone in Patients With Perennial Allergic Rhinitis

Rhinitis, Allergic, Perennial

3

Subscribe